SCHEMBL199154

SCHEMBL199154

[CH2]C(CCCCCCCCCCC)CCCCCCCCCCCCCCCC

nearest known ligand 0.50

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.50
THRB P10828 1/20 0.50
LMNA P02545 1/20 0.48
DNM1 Q05193 2/20 0.48
OPRM1 P35372 1/20 0.46
GPR84 Q9NQS5 3/20 0.42
FDPS P14324 3/20 0.42
SPHK1 Q9NYA1 1/20 0.42
FFAR1 O14842 1/20 0.42
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL200824 1.00 TSHR (0.50) TSHRTHRBLMNADNM1OPRM1
SCHEMBL8430564 1.00 TSHR (0.50) TSHRTHRBLMNADNM1OPRM1
SCHEMBL198605 1.00 TSHR (0.50) TSHRTHRBLMNADNM1OPRM1
SCHEMBL6658137 1.00 TSHR (0.50) TSHRTHRBLMNADNM1OPRM1
SCHEMBL2584365 1.00 TSHR (0.50) TSHRTHRBLMNADNM1OPRM1
SCHEMBL22129787 1.00 TSHR (0.50) TSHRTHRBLMNADNM1OPRM1
SCHEMBL22407241 1.00 TSHR (0.50) TSHRTHRBLMNADNM1OPRM1
SCHEMBL22407234 1.00 TSHR (0.50) TSHRTHRBLMNADNM1OPRM1
SCHEMBL22129682 1.00 TSHR (0.50) TSHRTHRBLMNADNM1OPRM1
SCHEMBL22129681 1.00 TSHR (0.50) TSHRTHRBLMNADNM1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3183250-B1 PROCESS FOR PREPARING CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL CLAP CO LTD (KR) 2023-10-04 EP disclosed
US-11441036-B2 2-phenylphenoxy-substituted perylene bisimide compounds and their use BASF SE 2022-09-13 US disclosed
CN-109803969-B 2-phenylphenoxy substituted perylene bisimide compounds and uses thereof 巴斯夫欧洲公司 2022-08-05 CN disclosed
EP-3183757-B1 ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING LIQUID MEDIUM CLAP CO LTD (KR) 2022-05-04 EP disclosed
EP-3224246-B1 4-OXOQUINOLINE COMPOUNDS BASF SE (DE) 2022-01-12 EP disclosed
US-11021610-B2 Perylene bisimides with rigid 2,2′-biphenoxy bridges BASF SE 2021-06-01 US disclosed
CN-107428775-B Cyanobenzoxanthene and benzothioxanthene compounds 巴斯夫欧洲公司 2020-11-03 CN disclosed
EP-3523303-B1 2-PHENYLPHENOXY-SUBSTITUTED PERYLENE BISIMIDE COMPOUNDS AND THEIR USE BASF SE (DE) 2020-09-23 EP disclosed
CN-107004768-B Organic semiconductor composition containing a liquid medium 巴斯夫欧洲公司 2020-08-21 CN disclosed
EP-3402845-B1 PERYLENE BISIMIDES WITH RIGID 2,2'-BIPHENOXY BRIDGES BASF SE (DE) 2020-03-11 EP disclosed
US-20110042651-A1 LIQUID CRYSTALLINE RYLENE TETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF BASF SE (DE) 2011-02-24 US disclosed
WO-2010111822-A1 OLIGOCONDENSED PERYLENE BISIMIDES BASF SE (DE) 2010-10-07 WO disclosed
WO-2010112452-A1 OLIGOCONDENSED PERYLENE BISIMIDES BASF SE (DE) 2010-10-07 WO disclosed
US-20100048904-A1 DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS BASF AKTIENGESELLSCHAFT (DE) 2010-02-25 US disclosed
CN-101467276-A Liquid crystalline rylene tetracarboxylic acid derivatives and use thereof MAX PLANCK GESELLSCHAFT (DE) 2009-06-24 CN disclosed
EP-2029573-A1 DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS BASF SE (DE) 2009-03-04 EP disclosed
EP-2008319-A2 LIQUID CRYSTALLINE RYLENE TETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF BASF SE (DE) 2008-12-31 EP disclosed
WO-2007138051-A1 DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS BASF SE (DE) 2007-12-06 WO disclosed
WO-2007116001-A2 LIQUID CRYSTALLINE RYLENE TETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF BASF SE (DE) 2007-10-18 WO disclosed
EP-1843407-A1 Liquid crystalline rylenetetracarboxylic acid derivatives and their use BASF AKTIENGESELLSCHAFT (DE) 2007-10-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048904-A1 DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS TDO2, C9, CYP3A43 TSHR 1062/4885THRB 1203/4885LMNA 1646/4885
US-20110042651-A1 LIQUID CRYSTALLINE RYLENE TETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF TPR, ROR1, CA3 TSHR 1618/4885THRB 2991/4885LMNA 2934/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.